相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy
Yan-ping Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The Diagnostic Utility of p16 Immunostaining in Differentiating Cancer and HSIL from LSIL and Benign in Cervical Cells
Ming-Zhe Wu et al.
CELL TRANSPLANTATION (2019)
Isolation of Biopsy-Derived, Human Cervical Keratinocytes Propagated as Monolayer and Organoid Cultures
Peter L. Villa et al.
SCIENTIFIC REPORTS (2018)
DNA demethylation pathways: Additional players and regulators
Matthias Bochtler et al.
BIOESSAYS (2017)
Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomase
Gary Kohanbash et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Genotype-specific methylation of HPV in cervical intraepithelial neoplasia
Yaw-Wen Hsu et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2017)
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Global Cancer in Women: Burden and Trend
Lindsey A. Torre et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
TET family dioxygenases and DNA demethylation in stem cells and cancers
Jungeun An et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none
Mariam El-Zein et al.
JOURNAL OF CLINICAL VIROLOGY (2016)
Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
Sung-Jong Lee et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2016)
Tumour hypoxia causes DNA hyper-methylation by reducing TET activity
Bernard Thienpont et al.
NATURE (2016)
Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers
Michael Christoph Haffner et al.
Oncotarget (2015)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation
H. Yang et al.
ONCOGENE (2013)
Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma
Christine Guo Lian et al.
CELL (2012)
Decreased 5-Hydroxymethylcytosine Is Associated with Neural Progenitor Phenotype in Normal Brain and Shorter Survival in Malignant Glioma
Brent A. Orr et al.
PLOS ONE (2012)
TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
Cyril Quivoron et al.
CANCER CELL (2011)
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Wei Xu et al.
CANCER CELL (2011)
5-Hydroxymethylcytosine Is Strongly Depleted in Human Cancers but Its Levels Do Not Correlate with IDH1 Mutations
Seung-Gi Jin et al.
CANCER RESEARCH (2011)
Reduced Functional Avidity Promotes Central and Effector Memory CD4 T Cell Responses to Tumor-Associated Antigens
Stefano Caserta et al.
JOURNAL OF IMMUNOLOGY (2010)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
分享论文
